首页> 外文期刊>Acta crystallographica. Section C, Structural chemistry. >A new polymorph of the gastrokinetic drug cisapride monohydrate
【24h】

A new polymorph of the gastrokinetic drug cisapride monohydrate

机译:胃内药物的新多晶型不同的单水合物

获取原文
获取原文并翻译 | 示例
           

摘要

Cisapride monohydrate (systematic name: 4‐amino‐5‐chloro‐ N ‐{(3 RS ,4 SR )‐1‐[3‐(4‐fluorophenoxy)propyl]‐3‐methoxypiperidin‐4‐yl}‐2‐methoxybenzamide monohydrate), C 23 H 29 ClFN 3 O 4 ·H 2 O, is a nondopamine‐blocking gastrokinetic drug. A new polymorph of cisapride monohydrate has been reported nearly three decades after the report of its first known crystal structure [Collin et al. (1989). J. Mol. Struct. 214 , 159–175]. The second polymorph is also monoclinic, but with different unit‐cell parameters. A comparison of both polymorphic forms shows that the difference is thus not in the molecular conformation but in the arrangements of molecules in the crystal packing. The crystal morphology of two forms was predicted with the BFDH model in Materials Studio and inferred that the powder of the new polymorph has better flowability than the original polymorph. The results of DSC (differential scanning calorimetry) analysis and slurry experiments show that both polymorphs are stable at room temperature.
机译:单水滴(系统名称:4-氨基-5-氯-N - {(3 rs,4 sr)-1- [3-(4-氟苯氧基)丙基] -3-甲氧基哌啶-4-基-2-甲氧基苯甲酰胺一水合物),C 23 H 29 CLFN 3 O 4·H 2 O,是嵌入甲胺醇封闭的胃内药物。在其第一已知的晶体结构的报告中,已经报告了近三十年的三十年的新多晶型物[Collin等人。 (1989)。 J.Mol。结构。 214,159-175]。第二多晶型物也是单斜核,但具有不同的单胞小组参数。两种多晶型形式的比较表明,差异不是在分子构象中,而是在晶体填料中分子的布置。使用材料工作室中的BFDH模型预测了两种形式的晶体形态,并推断出新的多晶型物的粉末具有比原始多晶型物更好的流动性。 DSC(差示扫描量热法)分析和浆料实验结果表明,两种多晶型物在室温下都是稳定的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号